Study may help explain effects of cannabidiol on seizure frequency in Lennox-Gastaut patients


Reviewed by Kate Anderton, B.Sc. (Editor) Nov 7 2019 Results from a study published in the British Journal of Clinical Pharmacology may help explain why cannabidiol–a chemical component of marijuana with no psychoactive properties–reduces the frequency of seizures in patients with a severe form of epilepsy. The effect may be explained by a drug-drug interaction between cannabidiol and the anti-seizure medication clobazam.

Ga naar Bron